logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Trump pressures drug prices, pharmaceutical stocks plummet

date
12/05/2025
According to the AI Finance APP, following US President Donald Trump's announcement of plans to lower prescription drug prices in the US to match those of other countries, pharmaceutical company stocks have plummeted.
Latest
1 m ago
Guggenheim: Reiterates rating on Kymera Therapeutics (KYMR.US) from Buy to Buy, target price adjusted from $52.00 to $52.00.
1 m ago
US pharmaceutical stocks fell across the board, as Trump plans to significantly lower drug prices raised industry concerns.
3 m ago
Scotiabank: Maintains rating on American Homes 4 Rent (AMH.US), adjusting from in line with market to in line with market, with a target price adjustment from $38.00 to $41.00.
4 m ago
Federal Reserve Governor Quarles: The uncertainty of tariffs has already had an impact on the economy.
4 m ago
The Dow Jones Industrial Average just broke through the 42,200.00 mark, with the latest report at 42,199.66, up 2.30% for the day.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.